Learning Objectives:

1.  Discuss New Potential novel therapy for obesity.
2.  Discuss GDF-15 physiology.
3.  Discuss and review Data in pre-clinical about the role of GDF-15.

 

Faculty Disclosure:

Shahd Bsazta, Presenter, has no relevant financial relationships to disclose.
Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Session date: 
12/13/2021 - 12:15pm to 1:15pm EST
Location: 
Boston University School of Medicine
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please login or register to take this course.